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Neonatal sepsis presents a diagnostic problem, as the signs are
nonspecific and there is no single reliable laboratory marker
available on presentation to rule out sepsis.  Many babies are
evaluated and treated for presumed sepsis with parenteral
antibiotics while awaiting final culture results.  Less than 10%
of these babies actually have sepsis, resulting in unnecessary
expense and hospitalisation — of relevance in developing
countries with limited resources.  Inflammatory markers
including interleukin 6 (IL6) and interleukin 8 (IL8), C-reactive
protein (CRP) and serum amyloid alpha have been evaluated
as markers of neonatal sepsis with varying success.  The best
prediction is obtained using a combination of markers.  Serum
procalcitonin (PCT) is one of many inflammatory markers and
is now available as a routine laboratory investigation.
PCT is the prohormone of calcitonin and occurs in very low
concentrations in the serum of healthy people. PCT is
preferentially induced in bacterial sepsis, especially in severe
sepsis and septic shock.1,2 PCT can therefore be used to
discriminate systemic inflammation due to bacterial sepsis
from other causes and can also be used to monitor the progress
and prognosis of patients with sepsis.1,3 PCT levels are higher in
non-survivors and decline with a good response to antibiotic
therapy.4  PCT has been used as a marker of bacterial sepsis in
both adult and paediatric patients, including neonates. 
The aim of the present study was to evaluate the role of PCT
as a single early marker of neonatal sepsis.  
Subjects and methods
The study was conducted in the neonatal unit of Johannesburg
Hospital between April and August 2002.  All neonates
undergoing sepsis evaluation were eligible for inclusion in the
study.  Evaluation for sepsis was done at the discretion of the
attending physician for a variety of reasons including maternal
risk factors for sepsis (e.g. prolonged rupture of membranes,
chorio-amnionitis, maternal pyrexia, maternal urinary tract
infection, foul-smelling liquor) and signs of neonatal sepsis,
e.g. temperature instability, lethargy, feeding intolerance,
seizures, ongoing respiratory distress, irritability, blood glucose
abnormalities, hypotension, poor perfusion, acidosis.  A baby
was entered in the study after written informed consent was
obtained from the parent or guardian.  The routine sepsis
evaluation included a full blood count (FBC) with total and
differential white cell count (WCC), platelet count, CRP (CRP1)
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Background. It has recently been suggested that procalcitonin
(PCT) is of value in the diagnosis of neonatal sepsis, with
varying results. This study was to evaluate the role of PCT as
a single early marker of neonatal sepsis.
Setting. Neonatal Unit, Johannesburg Hospital, and
Microbiology Laboratory, National Health Laboratory Service
(NHLS), South Africa.
Subjects and methods. Neonates undergoing evaluation for
sepsis between April and August 2002 were eligible for
inclusion.  Patients were categorised into ‘no infection’,
‘possible infection’ and ‘definite infection’ on the basis of 
C-reactive protein (CRP), white cell count (WCC), platelet
count and blood culture results.  PCT was correlated with
infection categories.  
Results. One hundred and eighty-three neonates were
enrolled.  One hundred and eighteen had no infection, 52
possible infection and 13 definite infection.  PCT differed
significantly among infection categories  (p < 0.0001) and
correlated significantly with CRP at presentation (correlation
coefficient 0.404, p < 0.001) and CRP at 24 hours (correlation
coefficient 0.343, p < 0.001). PCT predicted 89.5% of definite
infection. Receiver operating characteristic (ROC) analysis for
PCT to predict definite infection showed odds ratio (OR)
1.145 (95% confidence interval (CI): 1.05 - 1.25) with an area
under the curve of 0.778.  PCT had a negative predictive
value of 0.95 (95% CI: 0.915 - 0.988) for definite infection.
Conclusions. Although PCT was significantly related to the
category of infection, it is not sufficiently reliable to be the
sole marker of neonatal sepsis.  PCT would be useful as part
of a full sepsis evaluation, but is relatively expensive.  A
negative PCT on presentation may rule out sepsis, but this
needs to be evaluated further.  
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and blood cultures.  PCT was done at the time of presentation
with the initial sepsis evaluation. The CRP was repeated 24
hours after presentation as per the unit policy (CRP2).
Cerebrospinal fluid and urine cultures were done as clinically
indicated at the discretion of the attending physician. All
babies were started on parenteral antibiotics pending repeat
CRP and/or final blood culture results.  If CRP2 remained
negative and the baby was clinically well, antibiotic therapy




Babies were grouped into different categories of infection
before obtaining the PCT results, as follows:
No infection. Negative blood cultures with normal CRP1,
CRP2, platelet count and WCC. As there is a high incidence of
maternal problems including pregnancy-induced hypertension
and HIV infection, a single low platelet count or abnormal
WCC was not considered to be a reliable marker of infection
and such babies would be classified as having no infection. 
Possible infection. Negative blood cultures with abnormal
CRP1 and CRP2 or a combination of at least two of the
following: abnormal platelet count, WCC, CRP1 and CRP2.  
Definite infection. Positive blood cultures with any
abnormal CRP1, CRP2, platelet count or WCC.
Contamination. Positive blood cultures with normal CRP1,
CRP2, platelet count and WCC.
PCT levels were then compared between the different
categories of infection.
Statistical analysis
Descriptive statistics included mean and standard deviation
(SD) for continuous variables and proportions for categorical
variables.  The distribution of the data was skewed so non-
parametric statistics were used. Kruskal-Wallis one-way
analysis of variance was done to determine whether any
variables differed significantly among infection categories.
Spearman’s rank correlation and logistical regression were also
done to determine the best predictors of infection.  Receiver
operating characteristics (ROC) analysis was done to evaluate
the application of PCT as a diagnostic test for neonatal
infection.  
Ethical considerations
The Committee for Research on Human Subjects of the
University of the Witwatersrand approved the study.   Written
informed consent was obtained from the parent or guardian of
the infant before entering the study.  
Results
Two hundred and sixteen patients were entered into the study
— 28 were excluded because of incomplete data (e.g. missing
blood culture results, no PCT levels obtained).  A further 5
babies classified as having contaminated blood cultures were
also excluded. There were therefore 183 babies in the final
analysis.  The mean birth weight was 1 996 g (SD 893 g) and
gestational age 34.6 weeks (SD 4.3 weeks). The majority of
babies (167/183) were evaluated for sepsis within the first 72
hours of life.  There were 13 babies with definite infection, 52
with possible infection and 118 with no infection (as defined
above). There were 13 positive microbial isolates including 3
Klebsiella pneumoniae (1 with extended beta lactamase activity),
3 coagulase-negative staphylococci, 1 Escherichia coli, 2
Acinetobacter lwoffi, 1 Viridans streptococcus, 1 Streptococcus
agalactiae, 1 Acremonium spp. and 1 Candida albicans. The PCT
levels for the various categories of infection are shown in Table I.
One-way analysis of variance (Kruskal-Wallis) showed that
birth weight (p = 0.001), gestational age (p = 0.0005) and PCT 
(p < 0.0001) differed significantly among the categories of
infection.   (Note CRP1, CRP2 and platelet count were used to
define the different categories of infection and so are not
included in the above analysis.) Spearman’s rank correlation
showed that PCT correlated significantly with CRP1 (p < 0.001
correlation coefficient 0.404) and with CRP2 (p < 0.001
correlation coefficient 0.343).
Because of the likelihood that some babies in the ‘possible
infection’ group were in fact infected,  logistical regression and
ROC analysis  was done using ‘no infection’ versus ‘any
infection’ (possible/definite) and ‘no infection’ v. ‘definite
infection’.   PCT alone correctly predicted 72.5% of any
infection and 89.2% of definite infection.  If birth weight,
gestational age and platelets were added into the equation, the
prediction improved to 79.1% and 90.4% respectively.  The
predictive values for PCT using a cut off of 0.5 ng/ml are
shown in Table II. ROC analysis using PCT to predict ‘no
infection’ v. ‘any infection’ gave an odds ratio (OR) of 1.148
(95% CIs 1.06 - 1.23) with an area under the ROC curve of 0.75
(Fig. 1).  The OR for the prediction of PCT for ‘no infection’ v.
‘definite infection’ was 1.145 (95% CI: 1.05 - 1.25).  The area
under this ROC curve was 0.778 (Fig. 2).  
Table I. Procalcitonin levels among the different infection categories
PCT  
Number of level (median)
Category subjects (ng/ml) Range IQR
None 118 0.4 33.6 0.65
Possible 52 2.55 187.6 10.05
Definite 13 7.0 34.8 12.55
IQR = interquartile range (non-parametric equivalent of standard deviation).
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Discussion
The value of PCT in the diagnosis of neonatal sepsis is still
under evaluation. PCT has been shown to be useful in the
diagnosis, prognosis and response to treatment of patients with
neonatal sepsis.3,5 PCT may be a more reliable marker for early
onset neonatal sepsis within the first 12 hours of life than either
CRP or IL6.6,7  Also, umbilical cord blood PCT may be a useful
indicator in the diagnosis of early onset neonatal sepsis.8
However, specific cut-off values of PCT may be required in the
first 48 hours of life, as various maternal and perinatal factors
affect the PCT level.9 However, Blommendahl et al.10 report that
PCT does not offer any advantage over more conventional
markers of sepsis in neonates, especially CRP and the
immature-to-total neutrophil ratio.  PCT has also been shown
to have no value in predicting infection in paediatric patients.11
Our results show that although PCT is reasonably predictive
of neonatal sepsis, it is not sufficiently reliable to be used as the
sole marker of infection.  PCT would be useful as part of a
complete laboratory work-up for sepsis, rather than as a single
marker, as suggested by Giamarellos-Bourboulis et al.3
The negative predictive value for definite infection in our
study was 95%.  This is in agreement with Guibourdenche et
al.12 who have suggested that a negative PCT on presentation
may be useful to rule out sepsis in neonates.  This approach is
similar to our current unit policy where we discontinue
antibiotic therapy if the CRP2 (done at 24 hours) is negative.13
The high negative predictive value of PCT may allow a
negative PCT on presentation to rule out sepsis and limit
hospital stay and antibiotic use in neonates treated for
suspected sepsis. The PCT assay costs approximately R130
compared with approximately R30 for CRP.  Potential savings
in antibiotic use and hospital admissions, however, could
balance the relatively high cost of PCT.  This approach and
possible cost benefits need to be evaluated further before being
recommended as standard management.
Comments and criticisms
These data once again confirm the low incidence of actual
infection in neonates evaluated for sepsis and highlight the
large numbers of babies unnecessarily treated for this
condition.  A single reliable marker of infection at presentation
would solve this problem.  Unfortunately, our results do not
confirm that PCT is such a marker. 
Two of the isolates from the blood cultures in this study were
fungal and not bacterial.  We did not exclude these results from
the analysis, as these babies were clinically septic and PCT has
been reported to correlate with the severity and outcome of
fungal infection.14
Babies were categorised into 3 groups of infection, rather
than just present and absent infection as it is acknowledged
that some babies with sepsis will have negative blood cultures.
Therefore some of the babies with ‘possible’ sepsis will have
Fig. 1. ROC analysis for ‘no infection’ v. ‘any infection’.
Fig. 2. ROC analysis for ‘no infection’ v. ‘definite infection’.
Table II. Predictive values for PCT < 0.5 ng/ml (95% CI)
Infection category Sensitivity Specificity Positive predictive value Negative predictive value
None v. any 0.78 0.5 0.46 0.8
(0.725 - 0.844) (0.427 - 0.572) (0.391 - 0.535) (0.751 - 0.865)
None v. definite 0.769 0.5 0.14 0.95
(0.697 - 0.841) (0.414 - 0.586) (0.085 - 0.205) (0.915 - 0.988)
actual sepsis.  The analysis using ‘no infection’ v. ‘any
infection’ (possible and definite sepsis) and ‘no infection’  v.
‘definite infection’ was done  to cover this possibility.
Excluding the patients with possible infection would result in
the potential  exclusion of some patients with actual infection. 
Six of the organisms isolated in our study are of low
virulence (Acinetobacter lwoffi, streptococci viridans and
coagulase-negative staphylococci (CoNS)).  These organisms
may contaminate blood cultures.  These isolates were regarded
as significant in the present study because there were other
abnormal markers of infection.  Of interest is that the PCT level
was low in 3 of these patients.  This may indicate that these
were indeed contaminants, although the PCT response is less
marked in low-virulence organisms.5
Conclusions
Our results confirm the low incidence of culture-proven
neonatal sepsis.  Although PCT is reasonably predictive of
neonatal sepsis, it is not sufficiently reliable to be used as the
sole marker. PCT would be more useful as part of a full sepsis
evaluation.  A negative PCT on presentation may be useful to
rule out sepsis, but this should be evaluated further.
We wish to thank Humor Diagnostica Laboratories for
providing the kits for the PCT assay.
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